Quarterly Result12 Aug 2026, 03:35 pm
Indo Us Bio-Tech Declares Standalone Unaudited Q1 FY27 Results
AI Summary
Indo Us Bio-Tech Ltd announced its standalone unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results in a meeting held on August 12, 2026. The financial results were also reviewed by the Audit Committee and the Statutory Auditors provided a limited review report with an unmodified opinion. The company operates primarily in Seed Cultivation, Processing & Trading.
Key Highlights
- Standalone unaudited financial results declared for Q1 FY27.
- Board of Directors approved the results on August 12, 2026.
- Audit Committee and Statutory Auditors reviewed the results.
- Statutory Auditors issued an unmodified opinion.
- Company's main business segment is Seed Cultivation, Processing & Trading.
Price Impact
More from INDOUS